drugset / Trial / NCT03832517
Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 1 study of the safety, tolerability and pharmacokinetics of a new antibiotic (RC-01). In Part 1 cohorts of healthy adults will participate in a single dose escalation study of increasing intravenous doses of RC-01. In Part 2 cohorts of healthy adults will participate in a multiple dose escalation study of increasing intravenous doses of RC-01 given either twice daily or three times daily.
Timeline
- Start
- 2019-04-14
- Primary completion
- 2019-04-22
- Completion
- 2019-05-08
Outcome
Outcome not reported
Stopped: “safety”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | RC-01 | Unknown | 200 mg | Intravenous |
| Comparator | RC-01 | Unknown | 1600 mg | Intravenous |
Indications
No indication recorded.